AIDS AND LEGAL ACCESS TO STERILE DRUG INJECTION EQUIPMENT
In: The annals of the American Academy of Political and Social Science, Band 521, S. 42-65
ISSN: 0002-7162
LEGAL ACCESS TO STERILE INJECTION EQUIPMENT HAS BEEN A PRIMARY STRATEGY FOR PREVENTING THE SPREAD OF ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) AMONG INTRAVENOUS DRUG USERS IN ALMOST ALL DEVELOPED COUNTRIES. BUT THIS STRATEGY HAS REMAINED HIGHLY CONTROVERSIAL IN THE UNITED STATES, WITH ONLY A SMALL NUMBER OF LOCALITIES ADOPTING IT. IN THIS ARTICLE, THE AUTHORS REVIEW DIFFERENT TECHNIQUES FOR PROVIDING LEGAL ACCESS (OVER-THE-COUNTER SALES AND SYRINGE EXCHANGES), RESEARCH DESIGN ISSUES RELEVANT TO EVALUATING LEGAL-ACCESS PROGRAMS, AND THE FINDINGS FROM THE STUDIES CONDUCTED TO DATE. THE FINDINGS ARE CONSISTENT IN SHOWING DECREASES IN AIDS RISK BEHAVIOR AND NO INCREASE IN ILLICIT DRUG USE RELATED TO LEGAL-ACCESS PROGRAMS. THE DESIGN OF LEGAL-ACCESS PROGRAMS FOR MAXIMAL IMPACT AND THE ULTIMATE EFFECT OF THE DECREASES IN AIDS RISK BEHAVIOR ON TRANSMISSION OF THE HUMAN IMMUNODEFICIENCY VIRUS REMAIN TO BE DETERMINED.